NYSE:BBLN - Babylon Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $6.67
  • Forecasted Upside: 484.80 %
  • Number of Analysts: 6
  • Breakdown:
  • 0 Sell Ratings
  • 3 Hold Ratings
  • 3 Buy Ratings
  • 0 Strong Buy Ratings
$1.14
▼ -0.07 (-5.79%)

This chart shows the closing price for BBLN by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Babylon Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for BBLN and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for BBLN

Analyst Price Target is $6.67
▲ +484.80% Upside Potential
This price target is based on 6 analysts offering 12 month price targets for Babylon in the last 3 months. The average price target is $6.67, with a high forecast of $10.00 and a low forecast of $1.50. The average price target represents a 484.80% upside from the last price of $1.14.

This chart shows the closing price for BBLN for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 6 investment analysts is to buy stock in Babylon. This rating has held steady since December 2021, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
2/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
5/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
8/20/2021
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
11/18/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 2 hold ratings
  • 0 sell ratings
2/16/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 2 hold ratings
  • 0 sell ratings
4/17/2022
  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings
5/17/2022

Latest Recommendations

  • 0 strong buy ratings
  • 3 buy ratings
  • 3 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
5/16/2022Canaccord Genuity GroupLower Price TargetBuy ➝ Buy$8.00 ➝ $5.00High
5/13/2022CitigroupLower Price Target$5.00 ➝ $1.50High
4/28/2022Berenberg BankInitiated CoverageHold$5.50High
4/25/2022BTIG ResearchLower Price Target$15.00 ➝ $10.00High
3/11/2022Canaccord Genuity GroupLower Price TargetBuy ➝ Buy$14.00 ➝ $8.00Low
1/12/2022Deutsche Bank AktiengesellschaftInitiated CoverageBuy$9.00High
12/7/2021CitigroupInitiated CoverageNeutral$8.00High
12/1/2021Jefferies Financial GroupInitiated CoverageHold$9.00Medium
11/17/2021BTIG ResearchInitiated CoverageBuy$15.00Low
(Data available from 5/17/2017 forward)

News Sentiment Rating

0.15 (Hold)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
10/19/2021
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
11/18/2021
  • 0 very positive mentions
  • 2 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
12/18/2021
  • 1 very positive mentions
  • 3 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
1/17/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
2/16/2022
  • 1 very positive mentions
  • 3 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
3/18/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
4/17/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
5/17/2022

Current Sentiment

  • 2 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Babylon logo
Babylon Holdings Limited operates as a digital healthcare company. It offers end-to-end care solution that facilities through its digital health suite, virtual care, in-person medical care, and post-care offerings. The company also provides Babylon Cloud services. It operates in the United Kingdom, the United States, the Asia Pacific, Canada, and internationally. The company was founded in 2013 and is headquartered in London, the United Kingdom.
Read More

Today's Range

Now: $1.14
Low: $1.14
High: $1.21

50 Day Range

MA: $3.13
Low: $1.12
High: $5.21

52 Week Range

Now: $1.14
Low: $1.07
High: $16.00

Volume

33,749 shs

Average Volume

1,822,130 shs

Market Capitalization

$49.17 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Babylon?

The following sell-side analysts have issued research reports on Babylon in the last year: Berenberg Bank, BTIG Research, Canaccord Genuity Group Inc., Citigroup Inc., Deutsche Bank Aktiengesellschaft, Jefferies Financial Group Inc., and Zacks Investment Research.
View the latest analyst ratings for BBLN.

What is the current price target for Babylon?

6 Wall Street analysts have set twelve-month price targets for Babylon in the last year. Their average twelve-month price target is $6.67, suggesting a possible upside of 451.0%. BTIG Research has the highest price target set, predicting BBLN will reach $10.00 in the next twelve months. Citigroup Inc. has the lowest price target set, forecasting a price of $1.50 for Babylon in the next year.
View the latest price targets for BBLN.

What is the current consensus analyst rating for Babylon?

Babylon currently has 3 hold ratings and 3 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe BBLN will outperform the market and that investors should add to their positions of Babylon.
View the latest ratings for BBLN.

What other companies compete with Babylon?

How do I contact Babylon's investor relations team?

The company's listed phone number is 44 20 7100 0762 and its investor relations email address is [email protected] The official website for Babylon is www.babylonhealth.com. Learn More about contacing Babylon investor relations.